Often, our staff develops relationships that go far deeper than business and we are repeatedly touched by the dedication and perseverance that many of our clients show to their patients. This is precisely why we want to lend a helping hand as regularly as we can to help make their lives easier and the lives of their patients better.

Over the course of our 40 years in business, we have had some unique opportunities to donate our time and equipment to doing just that worldwide, notably, the Sickle Cell Unit in Jamaica and Peking University First Hospital in Beijing. While the work is not always easy and the challenges themselves can be of melancholy nature, it is a pleasure to help with research, testing, or bringing a service that was not previously offered.

Our philosophy is much more than providing the most accurate, connected, and simple lung function testing, but also helping our clients provide the best care possible for the good of the patient.

In the course of many years working with customers all over the world, our employees many times form bonds beyond that of the regular business relationship. Such is the case with the staff of the Sickle Cell Unit in the Tropical Medicine Research Institute at the University of the West Indies.

Visits to Kingston, Jamaica have always been enlightening; employees from our company have been struck by the grace and dedication shown by the staff at the Sickle Cell Center.

Work at the Center is challenging and sometimes quite upsetting, but the warmth of the Jamaican smiles and compassion for their patients always seems to shine through.

Collectively our employees felt they wanted to contribute to the work in Kingston and we hope that in some small way our support can make a difference.

Sickle cell disease (SCD) is an important health problem in Jamaica where one child in every 150 births has the disease and more than 10% of all adults are at risk of having an affected child. The World Health Organization estimates the births of children with SCD as 0.07/1000 infants in Europe, 0.49/1000 infants in American, 0.68/1000 infants in South-East Asia, 0.84/1000 infants in the eastern Mediterranean and 10.68/1000 infants in Africa.

In persons suffering from SCD the red blood cells are sickle shaped instead of being round. They damage and block the blood vessels and can cause problems affecting every organ in the body. The most common problem is pain in the bones which can be recurrent and severe. The most common cause of premature death is pulmonary disease.

The motto of the Sickle Cell Unit in Jamaica is “Improving lives through Research, Education and Clinical Care”. We provide free ambulatory health care to over four thousand people with SCD. Research undertaken here has changed the clinical management of every person in the world with SCD.

The provision of pulmonary function equipment and continued supply of testing accessories by Morgan Scientific is critical to improving the clinical care we provide for our patients and deepening the pulmonary research we undertake. The instruments provided will also be used to improve pulmonary health of other children attending the main academic hospital in Jamaica and to augment the learning experience of medical students and pediatricians in training. The Sickle Cell Unit, Tropical Medicine Research Institute, University of the West Indies deeply appreciates the support of Morgan Scientific and the good will with which it is given.

Jennifer Knight-Madden, M.D.
Senior Lecturer/Pediatric Pulmonologist.

Congenital Muscular Dystrophy: A group of diseases causing muscle weakness at birth. Several defined genetic mutations cause muscles to break down faster than they can repair or grow. A child with CMD may have various neurological or physical impairments. Some children never gain the ability to walk, while others lose the ability as they grow older.
To learn more about CMD, visit:

Some time ago we were approached by researchers in Philadelphia associated with a group that hitherto we were unfamiliar with, Cure CMD.

Their mission is to bring research, treatments and in the future, a cure for the Congenital Muscular Dystrophies (CMDs).

When our staff became aware of the challenges that patients face living with this disease and the dedication of the special people determined to find a cure we felt it important to help.

Patients with inherited muscle disorders can develop respiratory muscle weakness leading to ventilatory failure. Predicting the extent of respiratory involvement in the different types of inherited muscle disorders is important, as it allows clinicians to impart prognostic information and offers an opportunity for early interventional management strategies.

A special focus in ComPAS2 was to provide spirometry with Cough Peak Flow and Respiratory Muscle Strength (MIP/MEP) suitable for children and adults.

Adaptations were made to allow for calculation of height from ulna length, knee height, arm span and demi-span.

A research grade pneumotachograph was provided to Cure CMD for their work in China. Cure CMD has run an annual clinic with local staff: Dr. Hui Xiong, pediatric neurology and Dr. Chengli Que, pulmonology both from Peking First University Hospital and an American team of clinicians: Dr. Carsten Bonnemann (NINDS- pediatric neurology), Dr. Hank Mayer (CHOP-pediatric pulmonology) and Dr. David Spiegel (CHOP- orthopedics).

The Morgan Scientific pneumotachograph allowed a thorough evaluation of each of the 29 patients seen by the clinician team over 1 ½ days.  It is hoped that this will be the beginning of  many years association and that it will, in some small way, contribute to the understanding and eventual cure of a terminal disease.

“I cannot emphasize the tremendous gift that Morgan Scientific gave to the Chinese CMD families.  Seeing a 36 year old with severe scoliosis and compromised lung mechanics, fall asleep on BiPAP with more chest rise than he has probably ever seen in his entire lifetime was so poignant- knowing that this intervention is life-saving.

We were able to evaluate his lung mechanics with Morgan equipment and prioritize him as a key candidate to be admitted to the sleep lab out of the 29 patients evaluated.“

Dr Anne Rutkowski, Cure CMD Co-Founder and Board Member

A new machine to test for lung problems is up and running at a specialist clinic.

The pulmonary plethysmograph, used to check the efficiency of the lungs, has been installed at the new Bermuda Medical Specialities Group and will cut the need for patients to travel overseas for tests.

The equipment was developed by US company Morgan whose president, Patrick Morgan, is in Bermuda; to train staff at the multi-speciality practice in Hamilton’s Reid Street.

Mr Morgan, whose father was a co-developer of several respiratory tests, said: “Up until now, Bermudians have had to travel off island to get these tests done.

“They would have to go to Johns Hopkins Hospital, to the Harvard hospitals, to Vanderbilt Hospital or other fancy places, but now Bermuda has the exact equipment and medical support that they would have going off island.

Read Full Article at the Royal Gazette